SPDR S&P Biotech ETF $XBI Stock: Sowell Financial Services LLC Grows Position

Sowell Financial Services LLC lifted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 103.4% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,116 shares of the exchange traded fund’s stock after acquiring an additional 8,192 shares during the period. Sowell Financial Services LLC’s holdings in SPDR S&P Biotech ETF were worth $2,541,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Bank of America Corp DE lifted its stake in SPDR S&P Biotech ETF by 13.3% during the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. Main Street Research LLC increased its stake in SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock valued at $72,484,000 after purchasing an additional 206,953 shares during the last quarter. Strs Ohio raised its holdings in SPDR S&P Biotech ETF by 4.9% during the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after purchasing an additional 19,300 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in SPDR S&P Biotech ETF by 145.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after purchasing an additional 186,314 shares in the last quarter. Finally, Annex Advisory Services LLC raised its holdings in SPDR S&P Biotech ETF by 4.6% during the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock worth $42,019,000 after purchasing an additional 11,723 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 0.7%

Shares of NYSEARCA:XBI opened at $151.64 on Friday. The company has a market capitalization of $10.31 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a twelve month low of $106.30 and a twelve month high of $169.89. The firm has a 50 day simple moving average of $157.56 and a 200-day simple moving average of $147.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.